Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapy

References

• European Network of Cancer Registries. Eurocim V40 European Incidence database V23, 730 entity dictionary. Lyon: IARC; 2001.
   Google Scholar
• Organ M, Jewett M, Basiuk J, Morash C, Pautler S, Siemens DR, et al. Growth kinetics of small renal masses: a prospective analysis from the renal cell carcinoma consortium of Canada. Can Urol Assoc J 2014;8:24–7.
   PubMed Web of Science ®Google Scholar
• Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009;373:1119–32.
   PubMed Web of Science ®Google Scholar
• Kim HL, Zisman A, Han KR, Figlin RA, Belldegrun AS. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? J Urol 2004;171:588–91.
   PubMed Web of Science ®Google Scholar
• Martínez-Salamanca JI, Huang WC, Millan I, Bertini R, Bianco FJ, Carballido JA, et al. Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. Eur Urol 2011;59:120–7.
   PubMed Web of Science ®Google Scholar
• Miyake H, Terakawa T, Furukawa J, Muramaki M, Fujisawa M. Prognostic significance of tumor extension into venous system in patients undergoing surgical treatment for renal cell carcinoma with venous tumor thrombus. Eur J Surg Oncol 2012;38:630–6.
   PubMed Web of Science ®Google Scholar
• Giberti C, Oneto F, Martorana G, Rovida S, Carmignani G. Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases. Eur Urol 1997;31:40–8.
   PubMed Web of Science ®Google Scholar
• Tongaonkar HB, Dandekar NP, Dalal AV, Kulkarni JN, Kamat MR. Renal cell carcinoma extending to the renal vein and inferior vena cava: results of surgical treatment and prognostic factors. J Surg Oncol 1995;59:94–100.
   PubMed Web of Science ®Google Scholar
• Lambert EH, Pierorazio PM, Shabsigh A, Olsson CA, Benson MC, McKiernan JM. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus. Urology 2007;69:1054–8.
   PubMed Web of Science ®Google Scholar
• Klatte T, Pantuck AJ, Riggs SB, Kleid MD, Shuch B, Zomorodian N, et al. Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol 2007;178:1189–95.
   PubMed Web of Science ®Google Scholar
• Capitanio U, Cloutier V, Zini L, Isbarn H, Jeldres C, Shariat SF, et al. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. BJU Int 2009;103:1496–500.
   PubMed Web of Science ®Google Scholar
• Sankin A, Hakimi AA, Hsieh JJ, Molina AM. Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies. Front Oncol 2015;5:67.
   PubMed Web of Science ®Google Scholar
• Coppin C, Kollmannsberger C, Le L, Porzsolt F, Wilt TJ. Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials. BJU Int 2011;108:1556–63.
   PubMed Web of Science ®Google Scholar
• Ljungberg B. The role of metastasectomy in renal cell carcinoma in the era of targeted therapy. Curr Urol Rep 2013;14:19–25.
   PubMed Web of Science ®Google Scholar
• Eble JNSG, Epstein JI. Pathology and genetics of the tumours of the genitourinary system and male genital organs. WHO classification of tumours. Lyon: IARC Press; 2004.
   Google Scholar
• Sobim LH, Gospodarowicz MK, Wittekind C, UICC International Union Against Cancer. TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2009.
   Google Scholar
• Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205–13.
   PubMed Web of Science ®Google Scholar
• Martinez-Salamanca JI, Linares E, Gonzalez J, Bertini R, Carballido JA, Chromecki T, et al. Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Curr Urol Rep 2014;15:404.
   PubMed Web of Science ®Google Scholar
• Tilki D, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chromecki T, et al. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. Eur Urol 2014;66:577–83.
   PubMed Web of Science ®Google Scholar
• Ciancio G, Manoharan M, Katkoori D, De Los Santos R, Soloway MS. Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: single-center experience. Eur Urol 2010;57:667–72.
   PubMed Web of Science ®Google Scholar
• Wagner B, Patard JJ, Mejean A, Bensalah K, Verhoest G, Zigeuner R, et al. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Eur Urol 2009;55:452–9.
   PubMed Web of Science ®Google Scholar
• Tilki D, Hu B, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, et al. Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy. J Urol 2015;193:436–42.
   PubMed Web of Science ®Google Scholar
• Abel EJ, Margulis V, Bauman TM, Karam JA, Christensen WP, Krabbe LM, et al. Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis. BJU Int 2016;117:E87–94.
   PubMed Web of Science ®Google Scholar
• Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005;23:2763–71.
   PubMed Web of Science ®Google Scholar
• Steffens S, Janssen M, Roos FC, Becker F, Schumacher S, Seidel C, et al. Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma–a multicentre study. Eur J Cancer 2012;48:2347–52.
   PubMed Web of Science ®Google Scholar